Sana Biotechnology Inc vs Wayfair Inc — how do they compare? Sana Biotechnology Inc trades at $3.17 (market cap $873.84M), while Wayfair Inc trades at $84.8 (market cap $11.58B). The key difference: Wayfair Inc is far larger — about 13.3× Sana Biotechnology Inc's market cap, and Wayfair Inc is trading nearer its 52-week high, Sana Biotechnology Inc nearer its low. Which is the better fit depends on your goals.
| SANA | W | |
|---|---|---|
Market Cap | $873.84M | $11.58B |
Sector | Health | Consumer Cyclical |
52-Week High | $5.92 | $119.05 |
52-Week Low | $2.68 | $56.42 |
Enterprise Value | $848.03M | $14.16B |
Trailing returns across standard periods
Latest headlines on both assets
Sana Biotechnology Inc. is a clinical-stage biopharmaceutical company focused on creating and delivering engineered cells as medicines for patients. The company is developing cell therapies for various diseases, including oncology, diabetes, and central nervous system disorders. Sana's core strategy is built around two key technological platforms: in vivo gene delivery to repair cells inside the body and ex vivo cell engineering for therapeutic use.
Read more on SANA →Wayfair is a global leader in home goods, operating a massive digital marketplace that connects millions of consumers with thousands of suppliers. It utilizes an asset-light, inventory-light model combined with a proprietary logistics network (CastleGate) and an accelerating brick-and-mortar presence to deliver an end-to-end shopping experience for everything from decor to full home renovations.
Read more on W →